Generated record quarterly net revenues of $190.6 million, representing year-over-year growth of 44.8%Total Rare Disease quarterly net revenue of $87.0...
Reports record fourth quarter 2024 total revenue of $8.2 million, representing 30% growth compared to fourth quarter 2023; recurring revenue...
Reported promising safety and preliminary efficacy data for REC-617, an oral CDK7 inhibitor, and met primary endpoints and demonstrated encouraging...
LONDON, MADRID, and BOSTON, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Orchard Therapeutics, a Kyowa Kirin company, announced it has recently...
Daridorexant is a potential best-in-class treatment in the high-growth, dual orexin antagonist class of medicines treating sleep disorders, such as...
Leiden, the Netherlands, February 28, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in...
Building on success across its three clinical programs, Avidity is leading in rare neuromuscular diseases with a strong balance sheet...
This acquisition allows versatile analyses of pharmaceutical drug substances and drug products for both small molecules and large biologics. WEST...
Hosted by Arizona State University and Mayo ClinicAnivive provides $50,000 in travel awardsLeading global experts pioneering novel fungal vaccines, therapeutics...
PLEASANTON, Calif., Feb. 27, 2025 /PRNewswire/ -- Further enabling AI innovation for the life sciences industry, Veeva Systems (NYSE: VEEV)...
Identiv and Novanta to market new RFID-based solutions that fill much needed gap for medical device and pharmaceutical manufacturers SANTA...
Funding from OneOhio Recovery Foundation will drive technology-enabled recovery services and increase access to critical support for Ohioans impacted by...
-- Peer-Reviewed Paper Indicates Icosapent Ethyl (IPE) Reduced Composite Cardiovascular Endpoint Events Regardless of Baseline LDL-C Levels; Significantly Reduced Events...
This collaboration will expand Comprehensive Cell Solutions, a business unit of NYBCe, capabilities and geographic reach as a contract development...
PALO ALTO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Orbus Therapeutics, Inc., a private, late-stage biopharmaceutical company focused on the...
TEL AVIV, Israel, Feb. 27, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage...
Sportsgel signs first league-wide sports deal to be the official performance gel of the preeminent pickleball tour across the Oceania...
The Clinical Study is Expected to Randomize 36 Participants in Cleveland Clinic Abu Dhabi (CCAD) and Three Other Clinical Sites...
New insights from Clarivate examine strategic partnerships, API production, and innovation in the region LONDON, Feb. 27, 2025 /PRNewswire/ -- Clarivate...
SAN DIEGO, Calif., Feb. 26, 2025 /PRNewswire/ -- Abzena, the leading end-to-end integrated CDMO + CRO for complex biologics and...